Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática

Objective: To analyze the complex synergistic interaction between Covid-19 and Guillain-Barré Syndrome (GBS), exploring the clinical and epidemiological implications of this co-infection. It also seeks to evaluate the diagnostic and therapeutic challenges faced by co-infected patients and to discuss...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lumen et virtus 2024-09, Vol.15 (39), p.4091-4101
Hauptverfasser: Milani, Bruno Henrique, Marcelino, Mirella Montandon, Oliveira, Laís Maria de Sousa, Leite, Laura Souza, Forti, Maria Júlia Faria, Bernardes, Amanda Matos Martins, De Carvalho, Marina Borges Lopes, Melo, Victor Hugo Mundim, Calais, Rafael Costa, Bicalho, Ruan Júnio Lopes
Format: Artikel
Sprache:por
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4101
container_issue 39
container_start_page 4091
container_title Lumen et virtus
container_volume 15
creator Milani, Bruno Henrique
Marcelino, Mirella Montandon
Oliveira, Laís Maria de Sousa
Leite, Laura Souza
Forti, Maria Júlia Faria
Bernardes, Amanda Matos Martins
De Carvalho, Marina Borges Lopes
Melo, Victor Hugo Mundim
Calais, Rafael Costa
Bicalho, Ruan Júnio Lopes
description Objective: To analyze the complex synergistic interaction between Covid-19 and Guillain-Barré Syndrome (GBS), exploring the clinical and epidemiological implications of this co-infection. It also seeks to evaluate the diagnostic and therapeutic challenges faced by co-infected patients and to discuss public health strategies. Methodology: It is a systematic review focused on understanding the main aspects of Covid-19 co-infection and Guillain-Barré Syndrome (GBS). The research was guided by the question: 'What are the biological and immunological mechanisms underlying the interaction between SARS-CoV-2 and GBS and how do they affect susceptibility, disease progression and clinical manifestations of patients?'. To find answers, we searched the PubMed database using four descriptors combined with the Boolean term "AND": Guillain-Barre Syndrome, COVID-19, SARS-CoV-2, and COVID-19 Vaccines. This resulted in 562 articles. 14 articles were selected for analysis. Results: The reviewed evidence shows a significant association between COVID-19 and the development of Guillain-Barré Syndrome (GBS), especially in older men. The pathogenesis suggests that the inflammatory response triggered by COVID-19 may contribute to the emergence of GBS. The infection aggravates respiratory complications in patients with GBS, increasing the need for early ventilation. Immunomodulatory therapies, such as intravenous immunoglobulin (IVIg), are effective and safe in the management of these patients Conclusion:The review highlights the importance of early diagnosis and close clinical monitoring to improve outcomes. Objetivo: Analisar a complexa interação sinérgica entre o Covid-19 e a Síndrome de Guillain-Barré (SGB), explorando as implicações clínicas e epidemiológicas dessa coinfecção. Busca-se também avaliar os desafios diagnósticos e terapêuticos enfrentados pelos pacientes co-infectados e discutir as estratégias de saúde pública. Metodologia:  É uma revisão sistemática focada em entender os aspectos principais da coinfecção de Covid-19 e a Síndrome de Guillain-Barré (SGB). A pesquisa foi guiada pela pergunta: ‘Quais são os mecanismos biológicos e imunológicos subjacentes à interação entre SARS-CoV-2 e SGB e como eles afetam a susceptibilidade, progressão da doença e as manifestações clínicas dos doentes?’. Para encontrar respostas, foram realizadas buscas na base de dados PubMed usando quatro descritores combinados com o termo booleano “AND”:Guillain-Barre Syndrome, COVID-19, SARS-
doi_str_mv 10.56238/levv15n39-191
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_56238_levv15n39_191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_56238_levv15n39_191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c791-d0a286b928a70d95eebb1f3917b71a15de772031acd9ef53a593cb1ed60753823</originalsourceid><addsrcrecordid>eNpNkMFKw0AQhoMoWGqvnvcBTN3NkmzWm1athUoPVq9hsjuRLUm27KYFb76DL6B4KB7Eh8ib-CTGKuJc_mEYvh--IDhkdBgnEU-PS1yvWVxzGTLJdoJexIQII5HK3X_7fjDwfkG7SWgsGO0FH9eooDa-sp74Vb4AhXWDnrTPRFlTF6jaTftqSXd1SEazu8l5V0CQ-Pa91s5WSDSS8cqUJZg6PAPn2rcTcrPyCpeNyU1pNGg8Iktn7x16_w3TQLTFut1ABzLVElRjiSo7olGWfD4-kdsKiMO12b574xus2pfGKDgI9gooPQ5-sx_MLy_mo6twOhtPRqfTUAnJQk0hSpNcRikIqmWMmOes4JKJXDBgsUYhIsoZKC2xiDnEkqucoU6oiHka8X4w_MEqZ713WGRLZypwDxmj2VZ49ic864TzL0dGfwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Milani, Bruno Henrique ; Marcelino, Mirella Montandon ; Oliveira, Laís Maria de Sousa ; Leite, Laura Souza ; Forti, Maria Júlia Faria ; Bernardes, Amanda Matos Martins ; De Carvalho, Marina Borges Lopes ; Melo, Victor Hugo Mundim ; Calais, Rafael Costa ; Bicalho, Ruan Júnio Lopes</creator><creatorcontrib>Milani, Bruno Henrique ; Marcelino, Mirella Montandon ; Oliveira, Laís Maria de Sousa ; Leite, Laura Souza ; Forti, Maria Júlia Faria ; Bernardes, Amanda Matos Martins ; De Carvalho, Marina Borges Lopes ; Melo, Victor Hugo Mundim ; Calais, Rafael Costa ; Bicalho, Ruan Júnio Lopes</creatorcontrib><description>Objective: To analyze the complex synergistic interaction between Covid-19 and Guillain-Barré Syndrome (GBS), exploring the clinical and epidemiological implications of this co-infection. It also seeks to evaluate the diagnostic and therapeutic challenges faced by co-infected patients and to discuss public health strategies. Methodology: It is a systematic review focused on understanding the main aspects of Covid-19 co-infection and Guillain-Barré Syndrome (GBS). The research was guided by the question: 'What are the biological and immunological mechanisms underlying the interaction between SARS-CoV-2 and GBS and how do they affect susceptibility, disease progression and clinical manifestations of patients?'. To find answers, we searched the PubMed database using four descriptors combined with the Boolean term "AND": Guillain-Barre Syndrome, COVID-19, SARS-CoV-2, and COVID-19 Vaccines. This resulted in 562 articles. 14 articles were selected for analysis. Results: The reviewed evidence shows a significant association between COVID-19 and the development of Guillain-Barré Syndrome (GBS), especially in older men. The pathogenesis suggests that the inflammatory response triggered by COVID-19 may contribute to the emergence of GBS. The infection aggravates respiratory complications in patients with GBS, increasing the need for early ventilation. Immunomodulatory therapies, such as intravenous immunoglobulin (IVIg), are effective and safe in the management of these patients Conclusion:The review highlights the importance of early diagnosis and close clinical monitoring to improve outcomes. Objetivo: Analisar a complexa interação sinérgica entre o Covid-19 e a Síndrome de Guillain-Barré (SGB), explorando as implicações clínicas e epidemiológicas dessa coinfecção. Busca-se também avaliar os desafios diagnósticos e terapêuticos enfrentados pelos pacientes co-infectados e discutir as estratégias de saúde pública. Metodologia:  É uma revisão sistemática focada em entender os aspectos principais da coinfecção de Covid-19 e a Síndrome de Guillain-Barré (SGB). A pesquisa foi guiada pela pergunta: ‘Quais são os mecanismos biológicos e imunológicos subjacentes à interação entre SARS-CoV-2 e SGB e como eles afetam a susceptibilidade, progressão da doença e as manifestações clínicas dos doentes?’. Para encontrar respostas, foram realizadas buscas na base de dados PubMed usando quatro descritores combinados com o termo booleano “AND”:Guillain-Barre Syndrome, COVID-19, SARS-CoV-2 e COVID-19 Vaccines. Isso resultou em 562 artigos. Sendo selecionado 14 artigos para análise. Resultados: As evidências revisadas mostram uma associação significativa entre COVID-19 e o desenvolvimento da Síndrome de Guillain-Barré (SGB), especialmente em homens idosos. A patogênese sugere que a resposta inflamatória desencadeada pela COVID-19 pode contribuir para o surgimento da SGB. A infecção agrava as complicações respiratórias em pacientes com SGB, aumentando a necessidade de ventilação precoce. As terapias imunomoduladoras, como a imunoglobulina intravenosa (IVIg), são eficazes e seguras no manejo desses pacientes Conclusão:A revisão destaca a importância do diagnóstico precoce e do monitoramento clínico rigoroso para melhorar os desfechos.</description><identifier>ISSN: 2177-2789</identifier><identifier>EISSN: 2177-2789</identifier><identifier>DOI: 10.56238/levv15n39-191</identifier><language>por</language><ispartof>Lumen et virtus, 2024-09, Vol.15 (39), p.4091-4101</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Milani, Bruno Henrique</creatorcontrib><creatorcontrib>Marcelino, Mirella Montandon</creatorcontrib><creatorcontrib>Oliveira, Laís Maria de Sousa</creatorcontrib><creatorcontrib>Leite, Laura Souza</creatorcontrib><creatorcontrib>Forti, Maria Júlia Faria</creatorcontrib><creatorcontrib>Bernardes, Amanda Matos Martins</creatorcontrib><creatorcontrib>De Carvalho, Marina Borges Lopes</creatorcontrib><creatorcontrib>Melo, Victor Hugo Mundim</creatorcontrib><creatorcontrib>Calais, Rafael Costa</creatorcontrib><creatorcontrib>Bicalho, Ruan Júnio Lopes</creatorcontrib><title>Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática</title><title>Lumen et virtus</title><description>Objective: To analyze the complex synergistic interaction between Covid-19 and Guillain-Barré Syndrome (GBS), exploring the clinical and epidemiological implications of this co-infection. It also seeks to evaluate the diagnostic and therapeutic challenges faced by co-infected patients and to discuss public health strategies. Methodology: It is a systematic review focused on understanding the main aspects of Covid-19 co-infection and Guillain-Barré Syndrome (GBS). The research was guided by the question: 'What are the biological and immunological mechanisms underlying the interaction between SARS-CoV-2 and GBS and how do they affect susceptibility, disease progression and clinical manifestations of patients?'. To find answers, we searched the PubMed database using four descriptors combined with the Boolean term "AND": Guillain-Barre Syndrome, COVID-19, SARS-CoV-2, and COVID-19 Vaccines. This resulted in 562 articles. 14 articles were selected for analysis. Results: The reviewed evidence shows a significant association between COVID-19 and the development of Guillain-Barré Syndrome (GBS), especially in older men. The pathogenesis suggests that the inflammatory response triggered by COVID-19 may contribute to the emergence of GBS. The infection aggravates respiratory complications in patients with GBS, increasing the need for early ventilation. Immunomodulatory therapies, such as intravenous immunoglobulin (IVIg), are effective and safe in the management of these patients Conclusion:The review highlights the importance of early diagnosis and close clinical monitoring to improve outcomes. Objetivo: Analisar a complexa interação sinérgica entre o Covid-19 e a Síndrome de Guillain-Barré (SGB), explorando as implicações clínicas e epidemiológicas dessa coinfecção. Busca-se também avaliar os desafios diagnósticos e terapêuticos enfrentados pelos pacientes co-infectados e discutir as estratégias de saúde pública. Metodologia:  É uma revisão sistemática focada em entender os aspectos principais da coinfecção de Covid-19 e a Síndrome de Guillain-Barré (SGB). A pesquisa foi guiada pela pergunta: ‘Quais são os mecanismos biológicos e imunológicos subjacentes à interação entre SARS-CoV-2 e SGB e como eles afetam a susceptibilidade, progressão da doença e as manifestações clínicas dos doentes?’. Para encontrar respostas, foram realizadas buscas na base de dados PubMed usando quatro descritores combinados com o termo booleano “AND”:Guillain-Barre Syndrome, COVID-19, SARS-CoV-2 e COVID-19 Vaccines. Isso resultou em 562 artigos. Sendo selecionado 14 artigos para análise. Resultados: As evidências revisadas mostram uma associação significativa entre COVID-19 e o desenvolvimento da Síndrome de Guillain-Barré (SGB), especialmente em homens idosos. A patogênese sugere que a resposta inflamatória desencadeada pela COVID-19 pode contribuir para o surgimento da SGB. A infecção agrava as complicações respiratórias em pacientes com SGB, aumentando a necessidade de ventilação precoce. As terapias imunomoduladoras, como a imunoglobulina intravenosa (IVIg), são eficazes e seguras no manejo desses pacientes Conclusão:A revisão destaca a importância do diagnóstico precoce e do monitoramento clínico rigoroso para melhorar os desfechos.</description><issn>2177-2789</issn><issn>2177-2789</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkMFKw0AQhoMoWGqvnvcBTN3NkmzWm1athUoPVq9hsjuRLUm27KYFb76DL6B4KB7Eh8ib-CTGKuJc_mEYvh--IDhkdBgnEU-PS1yvWVxzGTLJdoJexIQII5HK3X_7fjDwfkG7SWgsGO0FH9eooDa-sp74Vb4AhXWDnrTPRFlTF6jaTftqSXd1SEazu8l5V0CQ-Pa91s5WSDSS8cqUJZg6PAPn2rcTcrPyCpeNyU1pNGg8Iktn7x16_w3TQLTFut1ABzLVElRjiSo7olGWfD4-kdsKiMO12b574xus2pfGKDgI9gooPQ5-sx_MLy_mo6twOhtPRqfTUAnJQk0hSpNcRikIqmWMmOes4JKJXDBgsUYhIsoZKC2xiDnEkqucoU6oiHka8X4w_MEqZ713WGRLZypwDxmj2VZ49ic864TzL0dGfwA</recordid><startdate>20240912</startdate><enddate>20240912</enddate><creator>Milani, Bruno Henrique</creator><creator>Marcelino, Mirella Montandon</creator><creator>Oliveira, Laís Maria de Sousa</creator><creator>Leite, Laura Souza</creator><creator>Forti, Maria Júlia Faria</creator><creator>Bernardes, Amanda Matos Martins</creator><creator>De Carvalho, Marina Borges Lopes</creator><creator>Melo, Victor Hugo Mundim</creator><creator>Calais, Rafael Costa</creator><creator>Bicalho, Ruan Júnio Lopes</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20240912</creationdate><title>Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática</title><author>Milani, Bruno Henrique ; Marcelino, Mirella Montandon ; Oliveira, Laís Maria de Sousa ; Leite, Laura Souza ; Forti, Maria Júlia Faria ; Bernardes, Amanda Matos Martins ; De Carvalho, Marina Borges Lopes ; Melo, Victor Hugo Mundim ; Calais, Rafael Costa ; Bicalho, Ruan Júnio Lopes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c791-d0a286b928a70d95eebb1f3917b71a15de772031acd9ef53a593cb1ed60753823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>por</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Milani, Bruno Henrique</creatorcontrib><creatorcontrib>Marcelino, Mirella Montandon</creatorcontrib><creatorcontrib>Oliveira, Laís Maria de Sousa</creatorcontrib><creatorcontrib>Leite, Laura Souza</creatorcontrib><creatorcontrib>Forti, Maria Júlia Faria</creatorcontrib><creatorcontrib>Bernardes, Amanda Matos Martins</creatorcontrib><creatorcontrib>De Carvalho, Marina Borges Lopes</creatorcontrib><creatorcontrib>Melo, Victor Hugo Mundim</creatorcontrib><creatorcontrib>Calais, Rafael Costa</creatorcontrib><creatorcontrib>Bicalho, Ruan Júnio Lopes</creatorcontrib><collection>CrossRef</collection><jtitle>Lumen et virtus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Milani, Bruno Henrique</au><au>Marcelino, Mirella Montandon</au><au>Oliveira, Laís Maria de Sousa</au><au>Leite, Laura Souza</au><au>Forti, Maria Júlia Faria</au><au>Bernardes, Amanda Matos Martins</au><au>De Carvalho, Marina Borges Lopes</au><au>Melo, Victor Hugo Mundim</au><au>Calais, Rafael Costa</au><au>Bicalho, Ruan Júnio Lopes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática</atitle><jtitle>Lumen et virtus</jtitle><date>2024-09-12</date><risdate>2024</risdate><volume>15</volume><issue>39</issue><spage>4091</spage><epage>4101</epage><pages>4091-4101</pages><issn>2177-2789</issn><eissn>2177-2789</eissn><abstract>Objective: To analyze the complex synergistic interaction between Covid-19 and Guillain-Barré Syndrome (GBS), exploring the clinical and epidemiological implications of this co-infection. It also seeks to evaluate the diagnostic and therapeutic challenges faced by co-infected patients and to discuss public health strategies. Methodology: It is a systematic review focused on understanding the main aspects of Covid-19 co-infection and Guillain-Barré Syndrome (GBS). The research was guided by the question: 'What are the biological and immunological mechanisms underlying the interaction between SARS-CoV-2 and GBS and how do they affect susceptibility, disease progression and clinical manifestations of patients?'. To find answers, we searched the PubMed database using four descriptors combined with the Boolean term "AND": Guillain-Barre Syndrome, COVID-19, SARS-CoV-2, and COVID-19 Vaccines. This resulted in 562 articles. 14 articles were selected for analysis. Results: The reviewed evidence shows a significant association between COVID-19 and the development of Guillain-Barré Syndrome (GBS), especially in older men. The pathogenesis suggests that the inflammatory response triggered by COVID-19 may contribute to the emergence of GBS. The infection aggravates respiratory complications in patients with GBS, increasing the need for early ventilation. Immunomodulatory therapies, such as intravenous immunoglobulin (IVIg), are effective and safe in the management of these patients Conclusion:The review highlights the importance of early diagnosis and close clinical monitoring to improve outcomes. Objetivo: Analisar a complexa interação sinérgica entre o Covid-19 e a Síndrome de Guillain-Barré (SGB), explorando as implicações clínicas e epidemiológicas dessa coinfecção. Busca-se também avaliar os desafios diagnósticos e terapêuticos enfrentados pelos pacientes co-infectados e discutir as estratégias de saúde pública. Metodologia:  É uma revisão sistemática focada em entender os aspectos principais da coinfecção de Covid-19 e a Síndrome de Guillain-Barré (SGB). A pesquisa foi guiada pela pergunta: ‘Quais são os mecanismos biológicos e imunológicos subjacentes à interação entre SARS-CoV-2 e SGB e como eles afetam a susceptibilidade, progressão da doença e as manifestações clínicas dos doentes?’. Para encontrar respostas, foram realizadas buscas na base de dados PubMed usando quatro descritores combinados com o termo booleano “AND”:Guillain-Barre Syndrome, COVID-19, SARS-CoV-2 e COVID-19 Vaccines. Isso resultou em 562 artigos. Sendo selecionado 14 artigos para análise. Resultados: As evidências revisadas mostram uma associação significativa entre COVID-19 e o desenvolvimento da Síndrome de Guillain-Barré (SGB), especialmente em homens idosos. A patogênese sugere que a resposta inflamatória desencadeada pela COVID-19 pode contribuir para o surgimento da SGB. A infecção agrava as complicações respiratórias em pacientes com SGB, aumentando a necessidade de ventilação precoce. As terapias imunomoduladoras, como a imunoglobulina intravenosa (IVIg), são eficazes e seguras no manejo desses pacientes Conclusão:A revisão destaca a importância do diagnóstico precoce e do monitoramento clínico rigoroso para melhorar os desfechos.</abstract><doi>10.56238/levv15n39-191</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2177-2789
ispartof Lumen et virtus, 2024-09, Vol.15 (39), p.4091-4101
issn 2177-2789
2177-2789
language por
recordid cdi_crossref_primary_10_56238_levv15n39_191
source EZB-FREE-00999 freely available EZB journals
title Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T05%3A58%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mecanismos%20subjacentes%20%C3%A0%20coinfec%C3%A7%C3%A3o%20entre%20COVID-19%20e%20s%C3%ADndrome%20de%20Guillain-Barr%C3%A9:%20Susceptibilidade,%20progress%C3%A3o%20da%20doen%C3%A7a%20e%20impacto%20cl%C3%ADnico%20%E2%80%93%20Uma%20revis%C3%A3o%20sistem%C3%A1tica&rft.jtitle=Lumen%20et%20virtus&rft.au=Milani,%20Bruno%20Henrique&rft.date=2024-09-12&rft.volume=15&rft.issue=39&rft.spage=4091&rft.epage=4101&rft.pages=4091-4101&rft.issn=2177-2789&rft.eissn=2177-2789&rft_id=info:doi/10.56238/levv15n39-191&rft_dat=%3Ccrossref%3E10_56238_levv15n39_191%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true